Non-Selective Beta-Blockers and Risk of Sepsis in Patients with Cirrhosis and Ascites: Results from a Large Observational Study

BACKGROUND AND AIMS: Previous studies have not been able to determine whether non-selective beta-blockers (NSBB) reduce the risk of sepsis in cirrhosis. We aimed to examine this question with data from 1198 patients with cirrhosis and ascites included in clinical studies of satavaptan, a vasopressin...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensen, Morten Daniel, Watson, Hugh, Vilstrup, Hendrik, Jepsen, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290839/
https://www.ncbi.nlm.nih.gov/pubmed/37366419
http://dx.doi.org/10.2147/CLEP.S400399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290839/
https://www.ncbi.nlm.nih.gov/pubmed/37366419
http://dx.doi.org/10.2147/CLEP.S400399

Ejemplares similares